期刊文献+

LY294002对CML急变期细胞中Wnt/β-catenin信号通路的影响及其效应

Effect of LY294002 on Wnt/β-catenin Pathway in CML Blastic Cells
原文传递
导出
摘要 β-catenin在慢性粒细胞白血病急变过程中发挥着重要作用,而其受BCR/ABL及其下游信号通路调控的具体分子机制尚未完全阐明。该研究旨在探讨PI3K-AKT信号通路对慢粒急变期细胞的影响及其对Wnt/β-catenin信号通路的调控作用。采用PI3K-AKT信号通路的靶向抑制剂LY294002作用于慢粒急变期K562细胞,MTT法检测其对细胞增殖的影响,甲基纤维素克隆形成实验检测细胞的克隆形成能力,Western blot检测pAKT(Thr308)的表达变化,RT-PCR和Western blot分别检测β-catenin及其下游靶基因c-myc、cyclinD1的mRNA和蛋白表达情况。结果显示,10,20,40μmol/L的LY294002作用细胞24 h后,抑制了K562细胞的增殖以及克隆形成能力,该效应呈浓度依赖的方式。3种浓度的LY294002处理细胞后,PI3K-AKT信号通路明显被抑制,pAKT(Thr308)的蛋白表达明显减少;β-catenin的mRNA表达无明显改变,但其蛋白水平依次减少;β-catenin的下游靶基因c-myc、cyclinD1的mRNA和蛋白水平均明显降低。综上所述,抑制PI3K-AKT信号通路可抑制白血病K562细胞的增殖和克隆形成能力,其机制可能与抑制Wnt/β-catenin信号通路相关。 β-catenin plays important roles in the progression of chronic myeloid leukemia blasts, whereas the relationship between β-catenin and the key pathways activated by BCR/ABL have not yet been elucidated. To investigate the impact of PI3K-AKT pathway on Wnt/β-catenin signal pathway, PI3K-AKT inhibitor LY294002 was used in CML blastic cells K562. Cell growth was detected by MTT test. The ability of cell colony was assessed by colony-forming assay. The protein expression of pAKT (Thr308) was detected by Western blot. The mRNA and protein expressions of β-catenin and its down-stream targets c-myc and cyclinD1 were analyzed by RT-PCR and Western blot, respectively. As a result, LY294002 significantly inhibited K562 cell growth and colony-forming ability in a dose-dependent manner. Meanwhile, the protein levels of pAKT (Thr308) and β-catenin were decreased in a dose-dependent manner after LY294002 treatment for 24 h, while the mRNA offl-catenin was not affected. Compared with the control groups, the mRNA and protein levels of c-myc and cyclinD1 were also decreased obviously after PI3K inhibitor treatment. Our data indicated that blockade of PI3K-AKT signaling inhibited the proliferation of CML blastic cells and the mechanism might be related to down-regulated expression of Wnt/ β-catenin pathway.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2014年第6期740-744,共5页 Chinese Journal of Cell Biology
基金 重庆市基础与前沿研究计划一般项目(批准号:cstc2012jjA0004)资助的课题~~
关键词 慢性粒细胞白血病 BCR ABL 急变期 β-catenin PI3K—AKT 信号通路 chronic myeloid leukemia BCR/ABL blast crisis β-catenin PI3K-AKT signaling transduction
  • 相关文献

参考文献11

  • 1Quintas-Cardama A, Cortes J. Molecular biology of BCRABLl-positive chronic myeloid leukemia. Blood 2009; 113(8): 1619-30.
  • 2Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA. JAKIISTAT, RafIIMEKlIERK, PI3K1IAkt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2000; 18(2): 189-218.
  • 3de Sousa EMF, Vermeulen L, Richel D, Medema JP. Targeting Wnt signaling in colon cancer stem cells. Clin Cancer Res 2011; 17(4): 647-53.
  • 4Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. New Engl J Med 2004; 351(7): 657-67.
  • 5Heidel Florian H, Bullinger L, Feng Z, Wang Z, Neff Tobias A, Stein L, et al. Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML. Cell Stem Cell 2012; 10(4): 412-24.
  • 6Staal FJT, Clevers HC. WNT signalling and haematopoiesis: A WNT-WNT situation. Nat Rev Immuno12005; 5(1): 21-30.
  • 7He T-C, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281(5382): 1509-12.
  • 8Tetsu O, McCormick F. β-Catenin regulates expression of cyc1in DI in colon carcinoma cells. Nature 1999; 398(6726): 422-6.
  • 9Coluccia AML, Vacca A, Dufiach M, Mologni L, Redaelli S, Bustos VH, et al. Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J 2007; 26(5): 1456-66.
  • 10Robertson BW, Chellaiah MA. Osteopontin induces β-catenin signaling through activation of Akt in prostate cancer cells. Exp Cell Res 2010; 316(1): 1-11.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部